Updates from around the Mölnlycke world

Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke^® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States. 

In November 2024, a National Advisory Board Meeting took place in Harrogate, UK. The meeting was attended by nine clinicians specialising in tissue viability, vascular and lower limb wound management.

This was the first of three meetings focused on identifying unmet needs in the management of complex lower limb wounds, particularly highly exuding lower leg wounds and diabetic foot ulcers, which pose significant challenges for patients, clinicians, and healthcare systems. These concepts were refined in subsequent meetings and case studies presented.

Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.